ACET
Adicet Bio Inc
7.10$
+4.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Adicet Bio Inc (ACET) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -95 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 23 | -15 | 14 | 13 | 24 | 25 | 25 | 8.3 | -12 | -18 | -28 | -42 | -51 | -45 | -94 | -92 | -95 | |
| 2.4 | 1.9 | 2.8 | 5.5 | 6.9 | 6.9 | 6.9 | 8.1 | 12 | 0.0 | 1.2 | 1.2 | 1.2 | 1.5 | 2.6 | 6.1 | 6.5 | 2.3 | |
| 1.3 | 1.6 | 1.0 | 0.9 | 1.2 | 1.8 | 1.8 | 3.2 | 4.5 | 0.5 | 2.5 | 1.2 | 5.3 | 13 | 17 | 20 | 22 | 14 | |
| 121 | 145 | -4.1 | -3.8 | -5.5 | 2.9 | 10 | 29 | 27 | 4.3 | -8.0 | 0.3 | -14 | -6.1 | 2.7 | 0.3 | -5.5 | 1.5 | |
| 1.2 | 0.6 | 4.0 | 5.4 | 1.1 | 1.0 | 1.0 | 1.1 | 0.6 | 0.0 | 0.9 | 1.1 | 1.0 | 13 | 17 | 4.5 | 1.1 | 1.7 | |
| 1.4 | -4.1 | -6.1 | -69 | -1.8 | -1.1 | -2.8 | -86 | -9.0 | 0.0 | -16 | -48 | 115 | -2.8 | -17 | -4.5 | -119 | 2.4 | |
| – | 4.9 | 5.1 | 5.2 | 5.3 | 6.0 | 6.0 | 6.8 | 7.0 | 7.1 | – | – | – | – | – | – | – | – | |
| – | – | – | – | -25 | -33 | -43 | -34 | -67 | -56 | – | – | – | – | -3.2 | -0.2 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | -0.2 | |
| -6.0 | -4.3 | -2.4 | 50 | -15 | -14 | -14 | 71 | -8.2 | 65 | 11 | 77 | 0.3 | 243 | 42 | 0.2 | 111 | 75 | |
| 14 | 11 | -27 | -2.2 | -3.8 | 8.4 | 8.4 | 9.7 | -8.9 | 30 | -23 | 1.1 | 74 | 189 | -20 | -98 | -100 | -18 | |
| 14 | 22 | -19 | 8.6 | 12 | 23 | 24 | 24 | 7.7 | -12 | -19 | -29 | -43 | -64 | -62 | -98 | -93 | -97 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.